What is APGE's dilution risk score?

APGE currently has a DilutionScore of 40/100, indicating medium dilution risk. DilutionWatch monitors APGE SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for APGE?

DilutionWatch tracks 25 SEC filing types for APGE including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect APGE shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For APGE, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for APGE tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for APGE. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

APGE Dilution Risk Score: 40/100 (MEDIUM)

📊 Score Breakdown

📋 Offering Ability

66

💰 Cash Runway

0

📊 Float Risk

25

⚠️ Warrant Exposure

15

🔄Convertible Debt—

🌦️ Dilution Forecast

☀️

Clear

No significant dilution signals

9%

💰 Capital Raise 18%

• Active ATM program with $350M remaining capacity

🔔 Track APGE — Get forecast alerts →

💹 Market Data

Market Cap$6.19B

Shares Outstanding74.88M

Float57.83M

Cash$1.06B

Debt$8.05M

Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 27.7% shares (2026Q1 vs prior)

231 institutional holders · 93.05M shares

#1 T. Rowe Price Investment Management, Inc. 10.30M shares

#2 FMR LLC 9.26M shares

#3 Venrock Adviser, LLC 8.49M shares

+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest5.16M

Days to Cover1.0

% of Float8.9%

FINRA data as of Jun 30, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

4 INSIDER TRANSACTION Apr 10, 2026

4 INSIDER TRANSACTION Apr 03, 2026

4 INSIDER TRANSACTION Mar 27, 2026

424B5 ATM Mar 25, 2026

Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for APGE Shareholders

Apogee Therapeutics, Inc. (APGE) has a DilutionScore of 40/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

APGE has an active ATM (at-the-market) program with $350.0M remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event.

DilutionWatch tracks over 25 SEC filing types for APGE in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for APGE alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

How ATM Offerings Work →